Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A series of 2-N-alkyl-3-aryl-3-alkoxyisoindolinones has been synthesised and evaluated as inhibitors of the MDM2-p53 interaction. The most potent compound, 3-(4-chlorophenyl)-3-(4-hydroxy-3,5-dimethoxybenzyloxy)-2-propyl-2,3-dihydroisoindol-1-one (NU8231), exhibited an IC50 of 5.3 +/- 0.9 microM in an ELISA assay, and induced p53-dependent gene transcription in a dose-dependent manner, in the SJSA human sarcoma cell line.


Journal article


Bioorganic & medicinal chemistry letters

Publication Date





1515 - 1520


Northern Institute for Cancer Research, School of Natural Sciences-Chemistry, Bedson Building, University of Newcastle upon Tyne, Newcastle upon Tyne, NE1 7RU, UK.


Cell Line, Tumor, Humans, Indoles, Proto-Oncogene Proteins, Nuclear Proteins, Transcription, Genetic, Molecular Structure, Protein Binding, Structure-Activity Relationship, Dose-Response Relationship, Drug, Models, Molecular, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-mdm2